Galmed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of liver diseases, primarily non-alcoholic steatohepatitis (NASH) and related conditions
The company’s lead product candidate aims to address the unmet medical needs of patients suffering from these chronic diseases by targeting the underlying mechanisms of liver damage and fibrosis. Through innovative research and development, Galmed is committed to advancing its pipeline of therapeutic solutions to improve patient outcomes and contribute to the evolving landscape of liver disease management.
Galmed Pharmaceuticals Ltd (NASDAQGLMD) shares are surging Thursday after the company announced plans to broaden its drug development activities over the next two years.
Shares of PriceSmart, Inc. (NASDAQPSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter.
Shares of Esperion Therapeutics, Inc. (NASDAQESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations.
Shares of Agenus Inc. (NASDAQAGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. NASDAQ: AGENNASDAQAGEN)
U.S. stocks traded lower toward the end of trading on Tuesday following the release of FOMC minutes. The Dow traded down 0.17% to 35,092.02 while the NASDAQ fell 0.59% to 14,200.33. The S&P 500 also fell, dropping, 0.17% to 4,539.87.
Shares of American Eagle Outfitters, Inc. (NYSEAEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the consensus of $1.28 billion. EPS of $0.49 surpassed the consensus of $0.48.
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Tuesday. The Dow traded down 0.25% to 35,062.35 while the NASDAQ fell 0.81% to 14,168.79. The S&P 500 also fell, dropping, 0.34% to 4,531.77.
